This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaida, S. J. Articles by Gaitini, L. A. Search for Related Content PubMed PubMed Citation Articles by Vaida, S. J. Articles by Gaitini, L. A. Related Collections Airway Equipment

---

TECHNOLOGY, COMPUTING, AND SIMULATION

A New Supraglottic Airway, the Elisha Airway Device: A Preliminary Study

Sonia J. Vaida, MD^*, Diana Gaitini, MD, Bruce Ben-David, MD, Mostafa Somri, MD^*, Carin A. Hagberg, MD, and Luis A. Gaitini, MD^*

*Department of Anesthesiology, Bnai-Zion Medical Center, Haifa, Israel; Department of Radiology, Rambam Medical Center, Haifa, Israel; Department of Anesthesiology, University of Pittsburgh Medical Centers, Pittsburgh, Pennsylvania; and Department of Anesthesiology, University of Texas-Houston Medical School, Houston, Texas

Address correspondence and reprint requests to Luis A. Gaitini, MD, Department of Anesthesiology, Bnai-Zion Medical Center, 31048, 47 Golomb St., Haifa, Israel. Address e-mail to sonia{at}netvision.net.il

We describe the Elisha Airway Device (EAD), a new reusable supraglottic ventilatory device. Its uniqueness consists of its ability to combine three functions in a single device: ventilation, blind and/or fiberoptic-aided intubation without interruption of ventilation, and gastric tube insertion. This study was performed in 70 ASA status I–II, Mallampati class I–II patients undergoing elective knee arthroscopy and receiving general anesthesia with mechanical ventilation. Anesthesia was induced with fentanyl and propofol and was maintained with isoflurane in N₂O/oxygen. Neuromuscular blockade was achieved with vecuronium. Blind insertion of the device was successful in 96% of patients, with a mean insertion time of 20 ± 4 s. In these patients it was possible to maintain oxygenation and ventilation throughout the surgical procedure. Gastric tube insertion was successful in all cases. Endotracheal intubation via the EAD was attempted in 20 patients. Blind intubation was possible during the first and second attempts in 15 and 2 patients, respectively. Fiberoptic intubation was then successful in two of the remaining three patients. The EAD is a new alternative in the evolution of supraglottic ventilatory devices; however, further clinical studies are necessary to evaluate its efficacy.

IMPLICATIONS: The ability of the Elisha Airway Device to perform three functions—ventilation, blind and/or fiberoptic-aided intubation without interruption of ventilation, and gastric tube insertion—was studied for the first time in patients receiving general anesthesia with mechanical ventilation.

This article has been cited by other articles:

				J. Brimacombe and C. Keller The Elisha Airway Device: Supraglottic and Infraglottic, or Simply Extraglottic? Anesth. Analg., February 1, 2005; 100(2): 603 - 603. [Full Text] [PDF]